New research shows that BBR effectively blocked cell death, oxidative damage, and inflammation in PD by specifically targeting the LINC00943/miR‐142‐5p/KPNA4/NF‐kappaB pathway (Li et al. 2021). Here, NFKB1 is linked to Parkinson disease.